Sunday, July 22
5:00 - 6:00 p.m.	Reception Location: Stanford Park Hotel, Woodside Foyer Hosted by Stanford University School of Medicine
6:00 - 7:45 p.m.	Dinner Meeting Location: Stanford Park Hotel, Woodside Room Welcome Hon. David Durenberger President, Medical Technology Leadership Forum Philip A. Pizzo, M.D. Dean, Stanford University School of Medicine Keynote Address: Greg Koski, Ph.D., M.D. Director, Office for Human Research Protections Department of Health and Human Services
7:45 - 8:00 p.m.	Case Study Introduction Mildred Cho, Ph.D. Senior Research Scholar, Stanford Center for Biomedical Ethics Kendra Dimond, J.D. Partner, Arent Fox Kintner Plotkin & Kahn, Washington, DC Paul Yock, M.D. Martha Meier Weiland Professor of Medicine, Stanford University Director, Medical Device Network & Center for Research in Cardiovascular Interventions
Monday, July 23 All sessions will be held in the Stanford University Littlefield Center, Wattis Room A shuttle to the Littlefield Center will depart from the Stanford Park Hotel promptly at 7:00 a.m.
7:15 - 7:30 a.m.	Continental Breakfast
7:30 - 7:45 a.m.	Welcome, Introductions and Meeting Purpose Kenneth Keller, Ph.D. Chairman, Medical Technology Leadership Forum Charles M. Denny, Jr., Professor of Science and Technology Hubert H. Humphrey Institute of Public Affairs, University of Minnesota Donald Kennedy, Ph.D. Bing Professor of Environmental Science and President Emeritus, Stanford University Editor, Science Former Commissioner, U.S. Food and Drug Administration
7:45 - 8:00 a.m.	Recap: Conflict of Interest Case Study Donald Kennedy, Ph.D. Program Overview: Key stakeholders from - Federal and state government - Universities - Patient advocacy groups - Physicians/professional medical organizations - Medical technology industry - Technology innovators Goals: Identify and analyze key policy issues related to the management of conflict of interest created by the relationship between industry and clinical researchers inherent in medical technology development, testing and transfer. Develop a profile of the risks and rewards associated with the collaboration between industry and clinical researchers in medical technology development, testing and transfer.
8:00 - 9:00 a.m.	Panel: Innovator/Physician Perspective This panel discussion features prominent physician inventors who have successfully developed and commercialized medical technologies with widely recognized benefit to patient care. Thomas Fogarty, M.D. Professor of Vascular Surgery, Stanford University Senior Partner, Three Arch Partners Rodney Perkins, M.D. Founder and Director, California Ear Institute John Simpson, M.D., Ph.D. Founder and Chairman, Fox Hollow Technologies, Inc.
9:00 - 10:00 a.m.	Panel: Government Perspective This panel discussion features policy makers from government agencies that have responsibility for the oversight of conflicts of interest in medical research. Greg Koski, Ph.D., M.D. Director, Office for Human Research Protections U.S. Department of Health and Human Services Belinda Seto, Ph.D. Deputy Director, Office of Extramural Research National Institutes of Health Grant Bagley, M.D., J.D. Partner, Arnold & Porter
10:00 - 10:15 a.m.	Break
10:15 - 11:15 a.m.	Patient and Research Advocate Perspective This panel discussion features leaders in advocacy for the interests of patients associated with clinical research, including both their interest in promoting research aimed at developing safe and effective treatments and their interest in ensuring the protection of human subjects involved in research. Phyllis Greenberger, M.S.W. President and CEO Society for Women's Health Research Alan Milstein, J.D. Sherman, Silverstein, Kohl, Rose & Podolsky Adjunct Faculty, Temple University School of Law
11:15 - 12:15 p.m.	Industry Perspective This panel discussion features representatives from the medical device manufacturing industry who are specifically involved with the interaction between corporate innovators and clinical research institutions. Patricia Garvey, Ph.D. Senior Vice President, Clinical & Regulatory Affairs Edwards Life Sciences LLC Neal E. Fearnot, Ph.D. President, MED Institute, Inc. Frank M. Fischer President and CEO, NeuroPace, Inc. Philip M. Young General Partner, US Venture Partners
12:15 - 1:30 p.m.	Lunch
1:30 - 2:45 p.m.	University and Research Institute Perspective The following experts will discuss the views of universities and other research institutions relating to the management and regulation of their relationships with industry arising from medical technology research. Eugene A. Bauer, M.D. Vice President, Medical Center Stanford University William Danforth, M.D. Chancellor Emeritus & Board of Trustees Vice Chairman Washington University, St. Louis Edward Holmes, M.D. Vice Chancellor-Health Sciences and Dean, School of Medicine University of California, San Diego Joseph Martin, M.D., Ph.D. Dean, Harvard Medical School
2:45 - 3:00 p.m.	Wrap-Up and Next Steps Kenneth Keller, Ph.D. Donald Kennedy, Ph.D.
3:00 p.m.	Adjournment